Trgovina Synaptogenix, Inc. - SNPX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | - | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | N/A |
| Odpri* | N/A |
| Enoletna sprememba* | N/A |
| Dnevni razpon* | N/A |
| Razpon 52 wk | 0.80-8.75 |
| Povprečni obseg (10 dni) | 70.79K |
| Povprečni obseg (3 meseci) | 1.87M |
| Tržna kapitalizacija | 6.10M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 6.85M |
| Prihodki | N/A |
| EPS | -2.07 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|
Synaptogenix, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 12.6183 | 12.8564 | 15.5135 | 11.1494 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 8.28189 | 8.08738 | 10.9725 | 6.26383 |
| Raziskave in razvoj | 4.33641 | 3.06903 | 4.54095 | 4.88556 |
| Prihodki iz poslovanja | -12.6183 | -12.8564 | -15.5135 | -11.1494 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.00711 | 0.15321 | 0.37871 | 0.12711 |
| Čisti dobiček pred obdavčitvijo | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
| Čisti dobiček po davkih | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
| Čisti dobiček pred dodatnimi postavkami | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
| Čisti dobiček | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
| Popravljen čisti dobiček | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
| Popravljene ponderirane povprečne delnice | 5.0151 | 1.25758 | 1.32211 | 1.32211 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -2.51465 | -12.0312 | -11.4474 | -8.33687 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -2.51465 | -10.6794 | -11.4474 | -8.33687 |
| Nenavadni odhodki (prihodki) | 0 | 1.7 | ||
| Total Adjustments to Net Income | -2.427 |
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 3.16721 | 3.79639 | 3.28253 | 4.23856 | 2.92938 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 1.68251 | 1.85529 | 1.79646 | 2.87693 | 2.09266 |
| Raziskave in razvoj | 1.48469 | 1.9411 | 1.48607 | 1.36164 | 0.83672 |
| Prihodki iz poslovanja | -3.16721 | -3.79639 | -3.28253 | -4.23856 | -2.92938 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.14073 | 0.04449 | 0.00461 | 0.00252 | 0.00245 |
| Čisti dobiček pred obdavčitvijo | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Čisti dobiček po davkih | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Čisti dobiček pred dodatnimi postavkami | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Čisti dobiček | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Popravljen čisti dobiček | -3.02648 | -3.7519 | -3.27792 | -4.23605 | -2.92693 |
| Popravljene ponderirane povprečne delnice | 6.988 | 6.9594 | 6.9392 | 6.7998 | 6.1966 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.4331 | -0.53911 | -0.47238 | -0.62297 | -0.47234 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.4331 | -0.53911 | -0.47238 | -0.62297 | -0.47234 |
| Nenavadni odhodki (prihodki) | 0 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 35.5042 | 6.72879 | 17.8762 | 29.4575 |
| Denarna sredstva in kratkoročne naložbe | 34.214 | 5.79506 | 17.382 | 28.8542 |
| Denarna sredstva in ustrezniki | 34.214 | 5.79506 | 17.382 | 28.8542 |
| Prepaid Expenses | 1.29023 | 0.80629 | 0.49411 | 0.60332 |
| Total Assets | 35.5247 | 6.751 | 17.8978 | 29.4784 |
| Property/Plant/Equipment, Total - Net | 0.02045 | 0.02221 | 0.02167 | 0.02084 |
| Total Current Liabilities | 1.99491 | 1.61249 | 0.47906 | 2.95708 |
| Accounts Payable | 1.29651 | 1.26034 | 0.41308 | 2.89858 |
| Accrued Expenses | 0.69841 | 0.35215 | 0.06598 | 0.05849 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.99491 | 1.61249 | 0.47906 | 2.95708 |
| Total Long Term Debt | 0 | 0 | 0 | 0 |
| Total Equity | 33.5298 | 5.13851 | 17.4188 | 26.5213 |
| Common Stock | 0.00067 | 0.0005 | 0.00131 | 0.00129 |
| Additional Paid-In Capital | 47.6707 | 6.66848 | 106.234 | 100.202 |
| Retained Earnings (Accumulated Deficit) | -14.1417 | -1.53047 | -88.8168 | -73.6821 |
| Total Liabilities & Shareholders’ Equity | 35.5247 | 6.751 | 17.8978 | 29.4784 |
| Total Common Shares Outstanding | 6.73018 | 1.25758 | 1.32211 | 1.32211 |
| Celotne terjatve, neto | 0.12745 | |||
| Other Equity, Total | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 32.3342 | 35.5042 | 32.3402 | 32.9402 | 16.3257 |
| Denarna sredstva in kratkoročne naložbe | 31.2817 | 34.214 | 31.2946 | 31.7021 | 14.8484 |
| Denarna sredstva in ustrezniki | 31.2817 | 34.214 | 31.2946 | 31.7021 | 14.8484 |
| Celotne terjatve, neto | 0 | 0 | |||
| Prepaid Expenses | 1.05247 | 1.29023 | 1.04551 | 1.23816 | 1.47723 |
| Total Assets | 32.3533 | 35.5247 | 32.3586 | 32.96 | 16.3466 |
| Property/Plant/Equipment, Total - Net | 0.01913 | 0.02045 | 0.01849 | 0.01973 | 0.02097 |
| Total Current Liabilities | 0.66934 | 1.99491 | 1.00733 | 0.76997 | 0.93744 |
| Accounts Payable | 0.40135 | 1.29651 | 0.93538 | 0.64816 | 0.75896 |
| Accrued Expenses | 0.26799 | 0.69841 | 0.07195 | 0.12181 | 0.17848 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.66934 | 1.99491 | 1.00733 | 0.76997 | 0.93744 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 31.684 | 33.5298 | 31.3513 | 32.19 | 15.4092 |
| Common Stock | 0.00068 | 0.00067 | 0.00062 | 0.0006 | 0.0014 |
| Additional Paid-In Capital | 49.1029 | 47.6707 | 41.2563 | 39.1681 | 20.0927 |
| Retained Earnings (Accumulated Deficit) | -17.4196 | -14.1417 | -9.90563 | -6.97869 | -4.68485 |
| Total Liabilities & Shareholders’ Equity | 32.3533 | 35.5247 | 32.3586 | 32.96 | 16.3466 |
| Total Common Shares Outstanding | 6.80965 | 6.73018 | 6.13697 | 6.0388 | 3.50813 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
| Denarna sredstva iz poslovanja | -8.71073 | -8.1024 | -11.8868 | -7.69677 |
| Denarna sredstva iz poslovanja | 0.00497 | 0.00487 | 0.00439 | 0.003 |
| Nedenarne postavke | 3.86958 | 3.90212 | 5.61236 | 2.21661 |
| Spremembe v obratnem kapitalu | 0.02593 | 0.69381 | -2.36881 | 1.10591 |
| Denarna sredstva pri naložbenju | -0.0032 | -0.00541 | -0.00521 | -0.00319 |
| Kapitalski izdatki | -0.0032 | -0.00541 | -0.00521 | -0.00319 |
| Denarna sredstva pri financiranju | 37.1329 | -3.47917 | 0.41984 | 20.441 |
| Izdaja (odplačilo) delnic, neto | 37.1344 | 16.5242 | 0.41984 | 20.441 |
| Neto sprememba denarnih sredstev | 28.4189 | -11.587 | -11.4722 | 12.7411 |
| Postavke denarnega toka pri financiranju | -0.00153 | -20.0034 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -3.27792 | -12.6112 | -8.37515 | -5.44822 | -3.15438 |
| Cash From Operating Activities | -3.48541 | -8.71073 | -6.66556 | -5.58532 | -3.58672 |
| Cash From Operating Activities | 0.00132 | 0.00497 | 0.00373 | 0.00249 | 0.00125 |
| Non-Cash Items | 0.87901 | 3.86958 | 2.4228 | 1.1348 | 0.91241 |
| Changes in Working Capital | -1.08781 | 0.02593 | -0.71694 | -1.27439 | -1.34599 |
| Cash From Investing Activities | -0.0032 | 0 | 0 | 0 | |
| Capital Expenditures | -0.0032 | 0 | 0 | 0 | |
| Cash From Financing Activities | 0.55315 | 37.1329 | 32.1651 | 31.4923 | 12.6401 |
| Financing Cash Flow Items | 0 | -0.00153 | -0.00153 | 0.12592 | 0.12745 |
| Issuance (Retirement) of Stock, Net | 0.55315 | 37.1344 | 32.1667 | 31.3664 | 12.5127 |
| Net Change in Cash | -2.93226 | 28.4189 | 25.4996 | 25.907 | 9.0534 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Alpha Capital Aktiengesellschaft | Holding Company | 4.1055 | 301977 | -29305 | 2021-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.0271 | 222654 | 159 | 2022-12-31 | LOW |
| Intracoastal Capital, L.L.C. | Corporation | 2.4304 | 178765 | 178365 | 2022-12-31 | MED |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8472 | 62316 | -159 | 2022-12-31 | LOW |
| Perry (George) | Individual Investor | 0.5438 | 40000 | 40000 | 2021-07-13 | |
| Silverman (Joshua) | Individual Investor | 0.5199 | 38238 | 0 | 2023-03-15 | LOW |
| Alkon (Daniel L M.D.) | Individual Investor | 0.4833 | 35547 | 0 | 2023-03-15 | MED |
| Citadel Advisors LLC | Hedge Fund | 0.4655 | 34238 | 34238 | 2022-12-31 | HIGH |
| Weinstein (Robert) | Individual Investor | 0.4513 | 33197 | -1 | 2023-03-15 | LOW |
| Singer (William S) | Individual Investor | 0.4487 | 33000 | 0 | 2023-03-15 | HIGH |
| Tuchman (Alan J) | Individual Investor | 0.4487 | 33000 | 0 | 2023-03-15 | HIGH |
| Cannell & Co. | Investment Advisor | 0.4079 | 30000 | -46220 | 2022-12-31 | LOW |
| Bernstein (Bruce T.) | Individual Investor | 0.3749 | 27578 | 0 | 2023-03-15 | LOW |
| Schechter (Jonathan L) | Individual Investor | 0.3705 | 27250 | 0 | 2023-03-15 | MED |
| Diametric Capital | Investment Advisor/Hedge Fund | 0.3609 | 26549 | -1172 | 2022-09-30 | HIGH |
| Platform Technology Partners LLC | Investment Advisor | 0.3418 | 25138 | 9106 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2733 | 20100 | 0 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2065 | 15188 | 348 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.1835 | 13500 | -3000 | 2022-12-31 | HIGH |
| Advisor Group, Inc | Investment Advisor | 0.1244 | 9148 | 8600 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Synaptogenix, Inc. Company profile
O družbi Synaptogenix, Inc.
Synaptogenix, Inc., prej Neurotrope BioScience, Inc., je biofarmacevtsko podjetje. Družba se osredotoča predvsem na razvoj zdravil za bolnike z nevrodegenerativnimi boleznimi in razvojnimi motnjami. Družba razvija platformo izdelkov za zdravljenje Alzheimerjeve bolezni, ki temelji na kandidatu za zdravilo, imenovanem bryostatin-1, ki je sintetiziran iz naravnega produkta (bryostatina), izoliranega iz morskega nevretenčarja. Bryostatin-1 je njegov glavni kandidat za zdravilo. Bryostatin-1 je aktivator proteinske kinaze C Epsilon (PKC e) in e, ki je bil prvotno razvit kot potencialno protirakavo zdravilo. Podjetje ocenjuje tudi terapevtske aplikacije briostatina za druge nevrodegenerativne ali kognitivne bolezni in disfunkcije, kot so sindrom krhkega X, multipla skleroza in bolezen Niemanna-Picka tipa C, ki so bile predmet predkliničnega testiranja.
| Industry: | Biotechnology & Medical Research (NEC) |
1185 Avenue Of The Americas, 3Rd Floor
10036
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com